Single HCC between 2 and 5 cm: The grey zone: Hepatologist's perspective

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 4, 2010, Pages 434-437

  Kudo, Masatoshi ^a   Chung, Hobyung ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Single HCC between 2 and 5 cm; Surgery

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; EPIRUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; RADIOFREQUENCY ABLATION; SURVIVAL RATE; TUMOR RECURRENCE; TUMOR VOLUME; CANCER STAGING; CATHETER ABLATION; COMPARATIVE STUDY; FOLLOW UP; JAPAN; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952113429     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0242-z     Document Type: Article

References (8)

1. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-36.
2. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol. 2001;35:421-30. (Pubitemid 32844200)
3. Makuuchi M. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38:37-51. (Pubitemid 350182575)
4. Kudo M, Okanoue T, Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology. 2007;72:S2-15.
5. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res. 2007;37:676-91. (Pubitemid 47054774)
6. Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, et al. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh Stage A cirrhosis is comparable with liver transplantation. Dig Dis. 2007;25:303-9. (Pubitemid 350014957)
7. Eguchi S, Kanematsu T, Arii S, Okazaki K, Omata M, Ikai I, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery. 2008;143:469-75. (Pubitemid 351406380)
8. Poon RT. Liver transplantation for solitary hepatocellular carcinoma less than 3 cm in diameter in Child A cirrhosis. Dig Dis. 2007;25:334-40. (Pubitemid 350014962)